MYOK insider filings
MyoKardia, Inc. — 13 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-11-19. Screen MYOK transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for MYOK between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — MyoKardia, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2020-11-19 | 4 | Harris Taylor C. — Chief Financial Officer | Code (U): 42,559 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 49,400 (derivative) · Disposition to issuer (D): 46,060 (derivative) | EDGAR |
| 2020-11-19 | 4 | AGARWAL SUNIL — Director | Code (U): 4,100 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · +1 more | EDGAR |
| 2020-11-19 | 4 | Fairey William — EVP, Chief Commercial Officer | Code (U): 42,199 · Disposition to issuer (D): 69,500 (derivative) · Disposition to issuer (D): 39,022 (derivative) | EDGAR |
| 2020-11-19 | 4 | Bauer Jake — Chief Business Officer | Code (U): 90,209 · Disposition to issuer (D): 16,530 (derivative) · Disposition to issuer (D): 8,748 (derivative) · Disposition to issuer (D): 35,150 (derivative) · Disposition to issuer (D): 57,400 (derivative) · Disposition to issuer (D): 34,000 (derivative) · +1 more | EDGAR |
| 2020-11-19 | 4 | Waynick Denelle J — Chief Legal Officer | Code (U): 25,000 · Disposition to issuer (D): 80,000 (derivative) | EDGAR |
| 2020-11-19 | 4 | GIANAKAKOS ANASTASIOS — President and CEO, Director | Code (U): 141,405 · Code (U): 129,407 · Code (U): 300,000 · Code (U): 7,000 · Code (U): 10,000 · Code (U): 53,087 · +8 more | EDGAR |
| 2020-11-19 | 4 | McDowell Robert Scott — Chief Scientific Officer | Code (U): 36,616 · Disposition to issuer (D): 87,074 (derivative) · Disposition to issuer (D): 40,816 (derivative) · Disposition to issuer (D): 36,735 (derivative) · Disposition to issuer (D): 27,211 (derivative) · Disposition to issuer (D): 79,850 (derivative) · +4 more | EDGAR |
| 2020-11-19 | 4 | Meeker David P — Director | Code (U): 4,100 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative) | EDGAR |
| 2020-11-19 | 4 | Popovits Kimberly J — Director | Code (U): 4,100 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative) | EDGAR |
| 2020-11-19 | 4 | PERRY MARK L — Director | Code (U): 29,508 · Disposition to issuer (D): 21,800 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · +1 more | EDGAR |
| 2020-11-19 | 4 | YARNO WENDY L — Director | Code (U): 5,508 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative) | EDGAR |
| 2020-11-19 | 4 | CRANSTON MARY B — Director | Code (U): 4,100 · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative) | EDGAR |
| 2020-10-30 | 4/A | CRANSTON MARY B — Director | Option exercise (M): 371 @ $11.69 · Sale (S): 371 @ $98.68 · Option exercise (M): 21,629 @ $11.69 · Sale (S): 300 @ $97.25 · Sale (S): 21,329 @ $96.59 | EDGAR |
Recent 8-K events — MyoKardia, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2020-11-17 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-10-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MYOK returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs